Contribution of ECT2 to Tubulointerstitial Fibrosis in the Progression of Chronic Kidney Disease

Overview

Journal Curr Med Sci

Specialty General Medicine

Date 2024 Oct 26

PMID 39460889

Authors

Kai-Xin Song

Hua Su

Affiliations

Soon will be listed here.

Abstract

Objective: Chronic kidney disease (CKD) is a complex disorder resulting from a combination of various environmental and genetic factors. Considerable efforts have been dedicated to elucidating its etiological mechanisms. Nevertheless, the pathogenic mechanism of CKD remains poorly understood, which hinders the development of effective therapeutic strategies. In this study, we aimed to identify novel mediators that could contribute to the development of CKD.

Methods: The ClinVar, STRING, MEME Suite, TRRUST, bedtools, GEO, and R Studio databases and software were used to analyze their common features and investigate potential CKD disease genes. Transcriptomic analysis, immunohistochemistry, qRT-PCR, and Western blotting were utilized to further validate the role of ECT2 in kidney fibrosis.

Results: In total, 26 CKD disease genes were obtained from the ClinVar database, and the STRING, MEME Suite, TRRUST, bedtools, and GEO databases and software were used to analyze their common properties and explore potential CKD disease genes. Epithelial cell transforming sequence 2 (ECT2), cyclin B 1, caspase 7 and collagen alpha-1 (IV) were identified as potential candidates for CKD progression. Weighted correlation network analysis (WGCNA) subsequently revealed the relationships between potential genes and CKD. The results of the transcriptomic analysis further confirmed that ECT2 expression was greater in the kidney tissue of CKD patients than in that of healthy controls. Next, immunohistochemistry and Western blotting demonstrated that ECT2 was predominantly expressed in the renal tubules of a unilateral ureteral obstruction (UUO) mouse model. Consistently, in vitro experiments revealed that ECT2 was upregulated in TGF-β1-treated HK-2 cells. Moreover, ECT2 overexpression or knockdown in HK-2 cells altered the intensity of fibrosis markers.

Conclusion: ECT2 significantly affects the development and progression of CKD, particularly in association with tubulointerstitial fibrosis.

References

Stevens P, Levin A . Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013; 158(11):825-30. DOI: 10.7326/0003-4819-158-11-201306040-00007. View

Xie Y, Bowe B, Mokdad A, Xian H, Yan Y, Li T . Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018; 94(3):567-581. DOI: 10.1016/j.kint.2018.04.011. View

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice H, Okpechi I . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981):1975-82. DOI: 10.1016/S0140-6736(14)61601-9. View

Foreman K, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M . Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018; 392(10159):2052-2090. PMC: 6227505. DOI: 10.1016/S0140-6736(18)31694-5. View

Provenzano M, Rotundo S, Chiodini P, Gagliardi I, Michael A, Angotti E . Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease. Int J Mol Sci. 2020; 21(16). PMC: 7461617. DOI: 10.3390/ijms21165846. View

van Acker B, Stroomer M, Gosselink M, Koomen G, Koopman M, Arisz L . Urinary protein excretion in normal individuals: diurnal changes, influence of orthostasis and relationship to the renin-angiotensin system. Contrib Nephrol. 1993; 101:143-50. DOI: 10.1159/000422123. View

Inker L, Astor B, Fox C, Isakova T, Lash J, Peralta C . KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014; 63(5):713-35. DOI: 10.1053/j.ajkd.2014.01.416. View

McCullough K, Morgenstern H, Saran R, Herman W, Robinson B . Projecting ESRD Incidence and Prevalence in the United States through 2030. J Am Soc Nephrol. 2018; 30(1):127-135. PMC: 6317596. DOI: 10.1681/ASN.2018050531. View

Langefeld C, Beck S, Bowden D, Rich S, Wagenknecht L, Freedman B . Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis. 2004; 43(5):796-800. DOI: 10.1053/j.ajkd.2003.12.043. View

10.

Freedman B, Volkova N, Satko S, Krisher J, Jurkovitz C, Soucie J . Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol. 2005; 25(6):529-35. DOI: 10.1159/000088491. View

11.

Fox C, Yang Q, Cupples L, Guo C, Larson M, Leip E . Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. J Am Soc Nephrol. 2004; 15(9):2457-61. DOI: 10.1097/01.ASN.0000135972.13396.6F. View

12.

Canadas-Garre M, Anderson K, Cappa R, Skelly R, Smyth L, McKnight A . Genetic Susceptibility to Chronic Kidney Disease - Some More Pieces for the Heritability Puzzle. Front Genet. 2019; 10:453. PMC: 6554557. DOI: 10.3389/fgene.2019.00453. View

13.

Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T . Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol. 1999; 147(5):921-8. PMC: 2169345. DOI: 10.1083/jcb.147.5.921. View

14.

Landrum M, Chitipiralla S, Brown G, Chen C, Gu B, Hart J . ClinVar: improvements to accessing data. Nucleic Acids Res. 2019; 48(D1):D835-D844. PMC: 6943040. DOI: 10.1093/nar/gkz972. View

15.

Westra H, Franke L . From genome to function by studying eQTLs. Biochim Biophys Acta. 2014; 1842(10):1896-1902. DOI: 10.1016/j.bbadis.2014.04.024. View

16.

Umans B, Battle A, Gilad Y . Where Are the Disease-Associated eQTLs?. Trends Genet. 2020; 37(2):109-124. PMC: 8162831. DOI: 10.1016/j.tig.2020.08.009. View

17.

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

18.

Bailey T, Johnson J, Grant C, Noble W . The MEME Suite. Nucleic Acids Res. 2015; 43(W1):W39-49. PMC: 4489269. DOI: 10.1093/nar/gkv416. View

19.

Han H, Cho J, Lee S, Yun A, Kim H, Bae D . TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2017; 46(D1):D380-D386. PMC: 5753191. DOI: 10.1093/nar/gkx1013. View

20.

Barrett T, Wilhite S, Ledoux P, Evangelista C, Kim I, Tomashevsky M . NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2012; 41(Database issue):D991-5. PMC: 3531084. DOI: 10.1093/nar/gks1193. View